Viewing Study NCT01896102


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-01-12 @ 1:18 PM
Study NCT ID: NCT01896102
Status: COMPLETED
Last Update Posted: 2022-04-25
First Post: 2013-03-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)
Sponsor: Genetix Biotherapeutics Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cerebral Adrenoleukodystrophy (CALD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adrenoleukodystrophy View
None X-linked adrenoleukodystrophy View
None Gene therapy View
None Hematopoietic stem cell View